Drug approved to help young patients battle a rare cancer
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.
Jan 2, 2023
0
57
Amino Acid, Peptide, or Protein: atezolizumab
Medical news and research articles
Clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS). The immunotherapy drug ...
Dec 28, 2022
0
95
Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial
Updated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in patients with localized muscle-invasive bladder cancer, reveal no significant safety ...
Oct 25, 2022
0
58
Immuno-oncology treatment pre-surgery safe and effective option for localized non-small cell lung cancer
New study data shows that the immuno-oncology drug, atezolizumab (marketed as Tecentriq) is a safe and effective treatment for stage IB-IIIB non-small cell lung cancer patients prior to lung cancer surgery. This is according ...
Sep 13, 2022
0
71
Overall survival interim analysis of a Phase III study of atezolizumab vs best supportive care in resected NSCLC
An interim analysis of overall survival data from the IMpower010 trial showed an overall survival trend in favor of atezolizumab in the PD-L1 TC > 1% stage II-IIIA population (OS HR, 0.71 [95% CI: 0.49, 1.03]), but not in ...
Aug 8, 2022
0
51
